| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Center for Mucosal and Vaccine Biology, Infectious Disease Section, Veteran Affairs Medical Center, University of Minnesota School of Medicine, Minneapolis, MN 55417;
Department of Veterinary Pathobiology, University of Minnesota College of Veterinary Medicine, St. Paul, MN 55108;
Oral Infection and Immunity Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892; and
§
Virginia Mason Research Center, Seattle, WA 98101
B cells of the largest Ig variable heavy chain gene (VH) family, VH3, are reportedly decreased in patients with late stage HIV-1 disease. This deficit may contribute to their impaired responses to infections and vaccines. We confirmed that the VH3 family was underrepresented in serum IgM proteins, with a 45% decrease in patients with advanced HIV-1 disease. However, the proportion of VH3 within VH(1–6) IgM mRNA from peripheral B cells did not differ from that of control subjects (mean ± SD, 57.1 ± 9.7 vs 61.1 ± 8.7%). Similarly, within VH(1–6) IgD mRNA, which even more closely represents the unstimulated naive repertoire, the relative expression of VH3 mRNA was comparable in the two groups. Moreover, the frequency of individual genes within the VH3 family for IgD, particularly genes which encode putative HIV-1 gp120 binding sites, also was normal in HIV-1-infected patients. However, VH3 family expression for IgG mRNA was significantly decreased (17%) and VH4 IgG was increased (33%) relative to other VH families in advanced HIV-1-infected patients. Thus, the changes in VH family expression were more readily apparent in previously activated IgG "memory" B cell populations and, likely, in cells actively producing IgM rather than in resting naive cells. The presence of a relatively normal naive VH3 IgM and IgD mRNA repertoire in resting cells supports the prospect that with proper stimulation, particularly in conjunction with effective antiviral therapy, vigorous humoral immune responses to infections and vaccines may be elicited in this high-risk population.
This article has been cited by other articles:
|
|
 |
|
  D. Capello, M. Martini, A. Gloghini, M. Cerri, S. Rasi, C. Deambrogi, D. Rossi, M. Spina, U. Tirelli, L. M. Larocca, et al. Molecular analysis of immunoglobulin variable genes in human immunodeficiency virus-related non-Hodgkin's lymphoma reveals implications for disease pathogenesis and histogenesis Haematologica, August 1, 2008; 93(8): 1178 - 1185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Subramaniam, N. French, and L.-a. Pirofski Cryptococcus neoformans-Reactive and Total Immunoglobulin Profiles of Human Immunodeficiency Virus-Infected and Uninfected Ugandans Clin. Vaccine Immunol., October 1, 2005; 12(10): 1168 - 1176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Badr, G. Borhis, D. Treton, C. Moog, O. Garraud, and Y. Richard HIV Type 1 Glycoprotein 120 Inhibits Human B Cell Chemotaxis to CXC Chemokine Ligand (CXCL) 12, CC Chemokine Ligand (CCL)20, and CCL21 J. Immunol., July 1, 2005; 175(1): 302 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. De Milito, A. Nilsson, K. Titanji, R. Thorstensson, E. Reizenstein, M. Narita, S. Grutzmeier, A. Sonnerborg, and F. Chiodi Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection Blood, March 15, 2004; 103(6): 2180 - 2186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. N. Weiser, D. Bae, C. Fasching, R. W. Scamurra, A. J. Ratner, and E. N. Janoff Antibody-enhanced pneumococcal adherence requires IgA1 protease PNAS, April 1, 2003; 100(7): 4215 - 4220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Scamurra, D. B. Nelson, X. M. Lin, D. J. Miller, G. J. Silverman, T. Kappel, J. R. Thurn, E. Lorenz, A. Kulkarni-Narla, and E. N. Janoff Mucosal Plasma Cell Repertoire During HIV-1 Infection J. Immunol., October 1, 2002; 169(7): 4008 - 4016. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
